Loading page content…
Loading page content…
Loading contract search results…
Loading contract details…
| Source: | Contracts Finder |
| Notice Type: | Award notice |
| Buyer: | NHS England |
| Main Category: | Goods |
| Procurement Method: | Open procedure (above threshold) |
| Tender Status: | Closed |
| Estimated Value (ex. VAT): | £4,108,145,000 |
| Release Date: | 29 July 2025 |
| Application Deadline: | 7 April 2025 |
| Contract Start Date: | 31 August 2025 |
| Contract End Date: | 31 August 2027 |
| Contract Duration: | 2.0 years |
| Procurement ID (OCID): | ocds-b5fd17-04aa1520-7ead-4f1f-bebb-422062580323 |
| Notice Reference: | cc644418-f584-45db-bf35-771baf03bc48-856590 |
View Original Notice
Access the full notice on the official portal
Awarded to (21 suppliers)
| Award value: | £986,282,758 |
| Award decision date: | 30 June 2025 |
| Award status: | Active |
NHS Framework Agreement for Branded Medicines - Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025 CM/PHR/24/5680/01 - NHS Framework Agreement for Branded Medicines - Tranche B for North of England and Midlands & East. Period of Framework Agreement: 01 September 2025 to 31 August 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/PHR/24/5680/02 - NHS Framework Agreement for Branded Medicines - Eculizumab and Ravulizumab for London & SOFE. Period of Framework Agreement: 01 September 2025 to 31 August 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months.
Published contracts in the last 12 months
2,046
total contracts
£179666.3m
total value
£251,986,446
average contract size
Typical categories
Pipeline status
Not addedImports the contract into your BidWriter pipeline · Qualify before you commit to bid
Application Deadline
7 April 2025
Closed
Estimated Value
£4,108,145,000
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →